SEC Tracker
Get the app

Halozyme Therapeutics HALO

Torley Helen (President, CEO, Director) plans to sell 240,000 HALO shares, about $12.8M

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Jun 20, 2025
  2. Broker: J.P. Morgan Securities LLC
  3. Shares acquired by: Stock Option Exercise
  4. 10b5-1 plan adopted: Mar 21, 2025

All of Torley Helen's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 20,000 shares at $52.96 on Jun 20, 2025 · Form 4
  • Sold 20,000 shares at $52.57 on Jun 23, 2025 · Form 4
  • Sold 4,489 shares at $53.11 on Jun 24, 2025 · Form 4
  • Sold 15,511 shares at $53.91 on Jun 24, 2025 · Form 4
  • Sold 3,598 shares at $54.48 on Jul 8, 2025 · Form 4
  • Sold 16,402 shares at $55.74 on Jul 8, 2025 · Form 4
  • Sold 19,792 shares at $56.43 on Jul 9, 2025 · Form 4
  • Sold 208 shares at $57.08 on Jul 9, 2025 · Form 4
  • Sold 4,254 shares at $56.74 on Jul 10, 2025 · Form 4
  • Sold 15,746 shares at $57.62 on Jul 10, 2025 · Form 4
  • Sold 18,717 shares at $63.01 on Aug 11, 2025 · Form 4
  • Sold 1,283 shares at $63.6 on Aug 11, 2025 · Form 4
  • Sold 13,042 shares at $63.24 on Aug 12, 2025 · Form 4
  • Sold 6,958 shares at $64 on Aug 12, 2025 · Form 4
  • Sold 14,948 shares at $64.15 on Aug 13, 2025 · Form 4
  • Sold 5,052 shares at $64.83 on Aug 13, 2025 · Form 4
  • Sold 300 shares at $72.49 on Sep 2, 2025 · Form 4
  • Sold 16,288 shares at $73.7 on Sep 2, 2025 · Form 4
  • Sold 3,412 shares at $74.15 on Sep 2, 2025 · Form 4
  • Sold 9,500 shares at $74.22 on Sep 3, 2025 · Form 4
  • Sold 10,500 shares at $74.63 on Sep 3, 2025 · Form 4
  • Sold 9,900 shares at $73.54 on Sep 4, 2025 · Form 4
  • Sold 7,800 shares at $74.33 on Sep 4, 2025 · Form 4
  • Sold 2,300 shares at $75.22 on Sep 4, 2025 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Halozyme Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025
  2. Alkermes ALKS public float $4.7B, Jun 30, 2025
  3. Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
  4. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  5. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.